Bertrand William C JR
SEC insider (Form 3/4/5 filer). CIK 0001291937. Director at ARDELYX, INC. (ARDX) and 1 other issuer. 11 reported Form 4/5 transactions since Sep 2024; latest on Jun 16, 2026. Located in WALTHAM, MA.
Companies Bertrand William C JR has filed insider reports for
- ARDELYX, INC. (ARDX): Director
- Adaptimmune Therapeutics PLC (ADAP): Officer, Chief Operating Officer
Bertrand William C JR
CIK: 0001291937
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jun 16, 2026ARDX
ARDELYX, INC.
AwardDirect12.3K shares- - Jun 16, 2026ARDX
ARDELYX, INC.
AwardDirect26.5K shares- - Aug 28, 2025ADAP
Adaptimmune Therapeutics PLC
SaleDirect207K shares at avg. $0.01$2K - Jun 18, 2025ARDX
ARDELYX, INC.
AwardDirect19.4K shares- - Jun 18, 2025ARDX
ARDELYX, INC.
AwardDirect41.6K shares- - Feb 20, 2025ADAP
Adaptimmune Therapeutics PLC
AwardDirectOption to purchase Ordinary Shares
1.1M shares- - Feb 20, 2025ADAP
Adaptimmune Therapeutics PLC
AwardDirectOption to purchase Ordinary Shares
1.6M shares- - Jan 17, 2025ADAP
Adaptimmune Therapeutics PLC
SaleDirect5.6K shares at avg. $0.58$3K - Jan 15, 2025ADAP
Adaptimmune Therapeutics PLC
SaleDirect9.8K shares at avg. $0.57$6K - Jan 13, 2025ADAP
Adaptimmune Therapeutics PLC
SaleDirect5.5K shares at avg. $0.59$3K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 16, 2026 |  ARDX ARDELYX, INC. | Award | 12,345 | - | $0 | Direct |
| Jun 16, 2026 | ARDX ARDELYX, INC. | Award | 26,455 | - | $0 | Direct |
| Aug 28, 2025 |  ADAP Adaptimmune Therapeutics PLC | Sale | 207,000 | $0.01 | $2,091 | Direct |
| Jun 18, 2025 | ARDX ARDELYX, INC. | Award | 19,390 | - | - | Direct |
| Jun 18, 2025 | ARDX ARDELYX, INC. | Award | 41,551 | - | - | Direct |
| Feb 20, 2025 | ADAP Adaptimmune Therapeutics PLC | Award Option to purchase Ordinary Shares | 1,074,696 | - | - | Direct |
| Feb 20, 2025 | ADAP Adaptimmune Therapeutics PLC | Award Option to purchase Ordinary Shares | 1,612,032 | - | - | Direct |
| Jan 17, 2025 | ADAP Adaptimmune Therapeutics PLC | Sale | 5,584 | $0.58 | $3,243 | Direct |
| Jan 15, 2025 | ADAP Adaptimmune Therapeutics PLC | Sale | 9,803 | $0.57 | $5,635 | Direct |
| Jan 13, 2025 | ADAP Adaptimmune Therapeutics PLC | Sale | 5,471 | $0.59 | $3,216 | Direct |
1-10 of 11 transactions